SEC-sourced researchBeta
CRSP
CRISPR Therapeutics AG
Company comparison ↗
Data passport
- CIK
- 0001674416
- Exchange
- Nasdaq
- Business activity
- — · SIC 2836
- Financial inputs
- 6/6
- Filing date
- Nov 16, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2023 | 371,206,000.0000 | Feb 12, 2026 |
| December 2024 | 37,314,000.0000 | Feb 12, 2026 |
| December 2025 | 3,510,000.0000 | Feb 12, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 3,510,000.0000 | -581,599,000.0000 | -345,014,000.0000 | 2,265,243,000.0000 | 343,430,000.0000 | Feb 12, 2026 |
| December 2024 | 37,314,000.0000 | -366,252,000.0000 | -142,774,000.0000 | 2,242,034,000.0000 | 309,954,000.0000 | Feb 12, 2026 |
| December 2023 | 371,206,000.0000 | -153,610,000.0000 | -260,375,000.0000 | — | — | Feb 12, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $3.51M | December 2025 | Feb 12, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $37.31M | December 2024 | Feb 12, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$581.6M | December 2025 | Feb 12, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$345.01M | December 2025 | Feb 12, 2026 | 10-K |
| Total assetsAssets | $2.27B | December 2025 | Feb 12, 2026 | 10-K |
| Total liabilitiesLiabilities | $343.43M | December 2025 | Feb 12, 2026 | 10-K |
New filings
- SCHEDULE 13G/ACRSP · CRISPR Therapeutics AGNov 16, 2026 · Other
- SCHEDULE 13G/ACRSP · CRISPR Therapeutics AGNov 13, 2026 · Other
- SCHEDULE 13GCRSP · CRISPR Therapeutics AGNov 10, 2026 · Other
- 144CRSP · CRISPR Therapeutics AGNov 6, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGNov 6, 2026 · Other
- 3CRSP · CRISPR Therapeutics AGNov 2, 2026 · Other
- 10-QCRSP · CRISPR Therapeutics AGNov 2, 2026 · Periodic
- 8-KCRSP · CRISPR Therapeutics AGNov 2, 2026 · Current event
- 4CRSP · CRISPR Therapeutics AGOct 28, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 28, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 28, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 28, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 21, 2026 · Other
- 3CRSP · CRISPR Therapeutics AGOct 21, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 20, 2026 · Other
- 8-KCRSP · CRISPR Therapeutics AGOct 19, 2026 · Current event
- 4CRSP · CRISPR Therapeutics AGOct 16, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 15, 2026 · Other
- 4CRSP · CRISPR Therapeutics AGOct 15, 2026 · Other
- 144CRSP · CRISPR Therapeutics AGOct 14, 2026 · Other